Tarsus Pharmaceuticals, Inc. (TARS) NASDAQ
65.04
+0.47(+0.73%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
65.04
+0.47(+0.73%)
Currency In USD
| Previous Close | 64.57 |
| Open | 65.03 |
| Day High | 65.2 |
| Day Low | 64.38 |
| 52-Week High | 85.25 |
| 52-Week Low | 38.51 |
| Volume | 337,547 |
| Average Volume | 571,218 |
| Market Cap | 2.77B |
| PE | -40.91 |
| EPS | -1.59 |
| Moving Average 50 Days | 68.89 |
| Moving Average 200 Days | 66.23 |
| Change | 0.47 |
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors
GlobeNewswire Inc.
Feb 18, 2026 1:30 PM GMT
David E. I. Pyott David E. I. Pyott, former Chairman and CEO of Allergan, Inc., was appointed to Tarsus Pharmaceuticals' Board of Directors. IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today ann
Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026
GlobeNewswire Inc.
Feb 17, 2026 9:30 PM GMT
IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Monday, February 23, 2026 to report its fourth quarter and full year 2
Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
GlobeNewswire Inc.
Oct 28, 2025 9:00 PM GMT
IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Tuesday, November 4, 2025 to report its third quarter 2025 financial r